Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Gambia
Gambia: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) was 82.0% in 2025. ◆ Volatile
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Gambia, 2016–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for meningococcal a conjugate (menga) vaccine immunization coverage (%) in Gambia is 82.0%, measured in 2025.
Compared with earlier readings it is down 9.9% on the previous year and up 51.9% over five years.
Over the whole period, meningococcal a conjugate (menga) vaccine immunization coverage (%) in Gambia peaked at 91.0% in 2024 and was at its lowest, 0.0%, in 2016.
Gambia ranks 3rd of 26 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) in Gambia, year by year
| Year | Value | Change |
|---|---|---|
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 35.0% | — |
| 2020 | 54.0% | +54.3% |
| 2021 | 73.0% | +35.2% |
| 2022 | 66.0% | -9.6% |
| 2023 | 86.0% | +30.3% |
| 2024 | 91.0% | +5.8% |
| 2025 | 82.0% | -9.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 8.8% | 0.0% | 35.0% | 4 |
| 2020s | 75.3% | 54.0% | 91.0% | 6 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Population ages 80 and above, female, per capita 0.0021 units per person (2025)
- Population ages 80 and above, male, annual growth rate 5 % change on previous year (2025)
- Population ages 80 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 80 and above, male, per capita 0.0017 units per person (2025)
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, per capita 0 units per person (2025)
Frequently asked questions
- What is meningococcal a conjugate (menga) vaccine immunization coverage (%) in Gambia?
- Meningococcal a conjugate (menga) vaccine immunization coverage (%) in Gambia was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest meningococcal a conjugate (menga) vaccine immunization coverage (%) recorded in Gambia?
- The highest recorded value was 91.0% in 2024.
- What is the lowest meningococcal a conjugate (menga) vaccine immunization coverage (%) recorded in Gambia?
- The lowest recorded value was 0.0% in 2016.
- How does Gambia rank for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Gambia ranks 3rd out of 26 countries with data for 2025.
- Where does this Gambia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).